You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 263 No. 12, March 23, 1990 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Original Contributions
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Risk of Seizures and Encephalopathy After Immunization With the Diphtheria-Tetanus-Pertussis Vaccine

Marie R. Griffin, MD, MPH; Wayne A. Ray, PhD; Edward A. Mortimer, MD; Gerald M. Fenichel, MD; William Schaffner, MD

JAMA. 1990;263(12):1641-1645.


Abstract

We evaluated the risks of seizures and other neurological events following diphtheria-tetanus-pertussis (DTP) immunization for 38 171 Tennessee Medicaid children who received 107 154 DTP immunizations in their first 3 years of life. There were 2 children with encephalitis; both had disease onset more than 2 weeks following DTP immunization. There were 277 children who had febrile seizures, 42 with afebrile seizures, and 37 with seizures associated with other acute neurological illness (acute symptomatic). The risk of febrile seizures in the 0 to 3 days following DTP immunization (n = 6) was 1.5 (95% confidence interval, 0.6 to 3.3) times that of the control period 30 or more days following DTP immunization. There was no evidence that in the 0 to 3 days following DTP immunization the risk of afebrile seizures (n = 1) or acute symptomatic seizures (n = 0) was increased. No child who was previously normal without a prior history of seizures had a seizure in the 0 to 3 days following immunization that marked the onset of either epilepsy or other neurological or developmental abnormality.

(JAMA. 1990;263:1641-1645)



Author Affiliations

From the Departments of Preventive Medicine (Drs Griffin, Ray, and Schaffner) and Neurology (Dr Fenichel), Vanderbilt University School of Medicine, Nashville, Tenn; and the Department of Epidemiology and Biostatistics, Case Western Reserve School of Medicine, Cleveland, Ohio (Dr Mortimer).


Footnotes

Reprint requests to Department of Preventive Medicine, Vanderbilt University School of Medicine, Nashville, TN 37232-2637 (Dr Griffin).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

A Population-Based, Postlicensure Evaluation of the Safety of a Combination Diphtheria, Tetanus, Acellular Pertussis, Hepatitis B, and Inactivated Poliovirus Vaccine in a Large Managed Care Organization
Zangwill et al.
Pediatrics 2008;122:e1179-e1185.
ABSTRACT | FULL TEXT  

Molecular Pathogenesis, Epidemiology, and Clinical Manifestations of Respiratory Infections Due to Bordetella pertussis and Other Bordetella Subspecies
Mattoo and Cherry
Clin. Microbiol. Rev. 2005;18:326-382.
ABSTRACT | FULL TEXT  

Decrease in Hospital Admissions for Febrile Seizures and Reports of Hypotonic-Hyporesponsive Episodes Presenting to Hospital Emergency Departments Since Switching to Acellular Pertussis Vaccine in Canada: A Report From IMPACT
Le Saux et al.
Pediatrics 2003;112:e348-348.
ABSTRACT | FULL TEXT  

Vaccination Fears: What the School Nurse Can Do
Greene
The Journal of School Nursing 2002;18:31-35.
FULL TEXT  

The Risk of Seizures after Receipt of Whole-Cell Pertussis or Measles, Mumps, and Rubella Vaccine
Barlow et al.
NEJM 2001;345:656-661.
ABSTRACT | FULL TEXT  

Vaccine Safety Datalink Project: A New Tool for Improving Vaccine Safety Monitoring in the United States
Chen et al.
Pediatrics 1997;99:765-773.
ABSTRACT | FULL TEXT  

Omission Bias and Pertussis Vaccination
Asch et al.
Med Decis Making 1994;14:118-123.
ABSTRACT  

Risk of Serious Acute Neurological Illness After Immunization With Diphtheria-Tetanus-Pertussis Vaccine: A Population-Based Case-Control Study
Gale et al.
JAMA 1994;271:37-41.
ABSTRACT  

The Immunization Status of Children With Spina Bifida
Raddish et al.
Arch Pediatr Adolesc Med 1993;147:849-853.
ABSTRACT  

Comparison of a Diphtheria and Tetanus Toxoids and Bicomponent Acellular Pertussis Vaccine With Diphtheria and Tetanus Toxoids and Whole-Cell Pertussis Vaccine in Infants
Pichichero et al.
Arch Pediatr Adolesc Med 1993;147:295-299.
ABSTRACT  

Pertussis Vaccines: Seeking a Better Mousetrap
Shapiro
JAMA 1992;267:2788-2790.
ABSTRACT  

Clinical Reactions and Immunogenicity of the BIKEN Acellular Diphtheria and Tetanus Toxoids and Pertussis Vaccine in 4- Through 6-Year-Old US Children
Bernstein et al.
Arch Pediatr Adolesc Med 1992;146:556-559.
ABSTRACT  

Brain Damage From Pertussis Immunization: A Canadian Neurologist's Perspective
Camfield
Arch Pediatr Adolesc Med 1992;146:327-331.
ABSTRACT  

A Pertussis Vaccine Myth Dies
FULGINITI
Arch Pediatr Adolesc Med 1990;144:860-861.
ABSTRACT  

ENCEPHALOPATHY AFTER DTP IMMUNIZATION IS A MYTH
JWatch General 1990;1990:7-7.
FULL TEXT  

'Pertussis Vaccine Encephalopathy': It Is Time to Recognize It as the Myth That It Is
Cherry
JAMA 1990;263:1679-1680.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1990 American Medical Association. All Rights Reserved.